Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis

Sean T. McCarthy, Shannan Tujios, Robert J. Fontana, Sahand Rahnama-Moghadam, B. Joseph Elmunzer, Richard S. Kwon, Erik J. Wamsteker, Michelle A. Anderson, James M. Scheiman, Grace H. Elta, Cyrus R. Piraka

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Endoscopic transpapillary gallbladder stent (ETGS) placement is a proposed minimally invasive alternative to cholecystectomy in high-risk patients with symptomatic gallbladder disease. Aims: To describe the safety and efficacy of ETGS placement in 29 consecutive patients without cirrhosis. Methods: A retrospective analysis of consecutive ETGS cases from 2005 to 2013 at a referral center was undertaken. Results: The mean age was 70 years (range 40–91), and 62 % were hospitalized. The most common indication for ETGS was acute calculus cholecystitis (52 %). Comorbidities precluding cholecystectomy included advanced cancer (45 %), severe cardiopulmonary disease (21 %), and advanced age/frailty (17 %). Eighty-six percent of the patients had an ASA class of III or IV, and the Charlson comorbidity index was >3 in 55 %. An ETGS was successfully placed in 22 patients (76 %) with 18 being successful on the first attempt. A percutaneous rendezvous approach was required to obtain cystic duct access in six patients (21 %). During a mean follow-up of 376 days, a sustained clinical response was noted in 90 % of the patients with a stent placed. No peri-procedural complications were noted. However, two patients developed delayed complications of abdominal pain and cholangitis. Six patients were alive with their original stent still in place at a mean follow-up of 2.5 years. Conclusions: ETGS is an effective and safe alternative to cholecystectomy in high-risk patients. Technical success can be facilitated by a percutaneous rendezvous technique. Our data and those of others suggest that scheduled stent exchanges may not be required unless a clinical change occurs.

Original languageEnglish (US)
Pages (from-to)2516-2522
Number of pages7
JournalDigestive Diseases and Sciences
Volume60
Issue number8
DOIs
StatePublished - Oct 7 2014

Fingerprint

Gallbladder
Stents
Fibrosis
Cholecystectomy
Comorbidity
Gallbladder Diseases
Cystic Duct
Acute Cholecystitis
Cholangitis
Calculi
Abdominal Pain
Referral and Consultation
Safety

Keywords

  • Cholecystitis
  • Cholecystostomy
  • ERCP
  • Gallbladder stent

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

McCarthy, S. T., Tujios, S., Fontana, R. J., Rahnama-Moghadam, S., Elmunzer, B. J., Kwon, R. S., ... Piraka, C. R. (2014). Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. Digestive Diseases and Sciences, 60(8), 2516-2522. https://doi.org/10.1007/s10620-014-3371-4

Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. / McCarthy, Sean T.; Tujios, Shannan; Fontana, Robert J.; Rahnama-Moghadam, Sahand; Elmunzer, B. Joseph; Kwon, Richard S.; Wamsteker, Erik J.; Anderson, Michelle A.; Scheiman, James M.; Elta, Grace H.; Piraka, Cyrus R.

In: Digestive Diseases and Sciences, Vol. 60, No. 8, 07.10.2014, p. 2516-2522.

Research output: Contribution to journalArticle

McCarthy, ST, Tujios, S, Fontana, RJ, Rahnama-Moghadam, S, Elmunzer, BJ, Kwon, RS, Wamsteker, EJ, Anderson, MA, Scheiman, JM, Elta, GH & Piraka, CR 2014, 'Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis', Digestive Diseases and Sciences, vol. 60, no. 8, pp. 2516-2522. https://doi.org/10.1007/s10620-014-3371-4
McCarthy, Sean T. ; Tujios, Shannan ; Fontana, Robert J. ; Rahnama-Moghadam, Sahand ; Elmunzer, B. Joseph ; Kwon, Richard S. ; Wamsteker, Erik J. ; Anderson, Michelle A. ; Scheiman, James M. ; Elta, Grace H. ; Piraka, Cyrus R. / Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. In: Digestive Diseases and Sciences. 2014 ; Vol. 60, No. 8. pp. 2516-2522.
@article{d0a9914fdb934030886a384211567725,
title = "Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis",
abstract = "Background: Endoscopic transpapillary gallbladder stent (ETGS) placement is a proposed minimally invasive alternative to cholecystectomy in high-risk patients with symptomatic gallbladder disease. Aims: To describe the safety and efficacy of ETGS placement in 29 consecutive patients without cirrhosis. Methods: A retrospective analysis of consecutive ETGS cases from 2005 to 2013 at a referral center was undertaken. Results: The mean age was 70 years (range 40–91), and 62 {\%} were hospitalized. The most common indication for ETGS was acute calculus cholecystitis (52 {\%}). Comorbidities precluding cholecystectomy included advanced cancer (45 {\%}), severe cardiopulmonary disease (21 {\%}), and advanced age/frailty (17 {\%}). Eighty-six percent of the patients had an ASA class of III or IV, and the Charlson comorbidity index was >3 in 55 {\%}. An ETGS was successfully placed in 22 patients (76 {\%}) with 18 being successful on the first attempt. A percutaneous rendezvous approach was required to obtain cystic duct access in six patients (21 {\%}). During a mean follow-up of 376 days, a sustained clinical response was noted in 90 {\%} of the patients with a stent placed. No peri-procedural complications were noted. However, two patients developed delayed complications of abdominal pain and cholangitis. Six patients were alive with their original stent still in place at a mean follow-up of 2.5 years. Conclusions: ETGS is an effective and safe alternative to cholecystectomy in high-risk patients. Technical success can be facilitated by a percutaneous rendezvous technique. Our data and those of others suggest that scheduled stent exchanges may not be required unless a clinical change occurs.",
keywords = "Cholecystitis, Cholecystostomy, ERCP, Gallbladder stent",
author = "McCarthy, {Sean T.} and Shannan Tujios and Fontana, {Robert J.} and Sahand Rahnama-Moghadam and Elmunzer, {B. Joseph} and Kwon, {Richard S.} and Wamsteker, {Erik J.} and Anderson, {Michelle A.} and Scheiman, {James M.} and Elta, {Grace H.} and Piraka, {Cyrus R.}",
year = "2014",
month = "10",
day = "7",
doi = "10.1007/s10620-014-3371-4",
language = "English (US)",
volume = "60",
pages = "2516--2522",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis

AU - McCarthy, Sean T.

AU - Tujios, Shannan

AU - Fontana, Robert J.

AU - Rahnama-Moghadam, Sahand

AU - Elmunzer, B. Joseph

AU - Kwon, Richard S.

AU - Wamsteker, Erik J.

AU - Anderson, Michelle A.

AU - Scheiman, James M.

AU - Elta, Grace H.

AU - Piraka, Cyrus R.

PY - 2014/10/7

Y1 - 2014/10/7

N2 - Background: Endoscopic transpapillary gallbladder stent (ETGS) placement is a proposed minimally invasive alternative to cholecystectomy in high-risk patients with symptomatic gallbladder disease. Aims: To describe the safety and efficacy of ETGS placement in 29 consecutive patients without cirrhosis. Methods: A retrospective analysis of consecutive ETGS cases from 2005 to 2013 at a referral center was undertaken. Results: The mean age was 70 years (range 40–91), and 62 % were hospitalized. The most common indication for ETGS was acute calculus cholecystitis (52 %). Comorbidities precluding cholecystectomy included advanced cancer (45 %), severe cardiopulmonary disease (21 %), and advanced age/frailty (17 %). Eighty-six percent of the patients had an ASA class of III or IV, and the Charlson comorbidity index was >3 in 55 %. An ETGS was successfully placed in 22 patients (76 %) with 18 being successful on the first attempt. A percutaneous rendezvous approach was required to obtain cystic duct access in six patients (21 %). During a mean follow-up of 376 days, a sustained clinical response was noted in 90 % of the patients with a stent placed. No peri-procedural complications were noted. However, two patients developed delayed complications of abdominal pain and cholangitis. Six patients were alive with their original stent still in place at a mean follow-up of 2.5 years. Conclusions: ETGS is an effective and safe alternative to cholecystectomy in high-risk patients. Technical success can be facilitated by a percutaneous rendezvous technique. Our data and those of others suggest that scheduled stent exchanges may not be required unless a clinical change occurs.

AB - Background: Endoscopic transpapillary gallbladder stent (ETGS) placement is a proposed minimally invasive alternative to cholecystectomy in high-risk patients with symptomatic gallbladder disease. Aims: To describe the safety and efficacy of ETGS placement in 29 consecutive patients without cirrhosis. Methods: A retrospective analysis of consecutive ETGS cases from 2005 to 2013 at a referral center was undertaken. Results: The mean age was 70 years (range 40–91), and 62 % were hospitalized. The most common indication for ETGS was acute calculus cholecystitis (52 %). Comorbidities precluding cholecystectomy included advanced cancer (45 %), severe cardiopulmonary disease (21 %), and advanced age/frailty (17 %). Eighty-six percent of the patients had an ASA class of III or IV, and the Charlson comorbidity index was >3 in 55 %. An ETGS was successfully placed in 22 patients (76 %) with 18 being successful on the first attempt. A percutaneous rendezvous approach was required to obtain cystic duct access in six patients (21 %). During a mean follow-up of 376 days, a sustained clinical response was noted in 90 % of the patients with a stent placed. No peri-procedural complications were noted. However, two patients developed delayed complications of abdominal pain and cholangitis. Six patients were alive with their original stent still in place at a mean follow-up of 2.5 years. Conclusions: ETGS is an effective and safe alternative to cholecystectomy in high-risk patients. Technical success can be facilitated by a percutaneous rendezvous technique. Our data and those of others suggest that scheduled stent exchanges may not be required unless a clinical change occurs.

KW - Cholecystitis

KW - Cholecystostomy

KW - ERCP

KW - Gallbladder stent

UR - http://www.scopus.com/inward/record.url?scp=84937515161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937515161&partnerID=8YFLogxK

U2 - 10.1007/s10620-014-3371-4

DO - 10.1007/s10620-014-3371-4

M3 - Article

C2 - 25287001

AN - SCOPUS:84937515161

VL - 60

SP - 2516

EP - 2522

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 8

ER -